Key Statistics for ALNX
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (SEK) (ttm)
|Est. EPS (SEK) (12/2013)
|Est. PEG Ratio
|Market Cap (M SEK)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ALNX
- Net Income (M/SEK)
Allebex AB is a venture capital company. The Company invests in and helps develop new life science companies that are active in medical technology, biotechnology, and pharmaceuticals.
More Company Profile & Key Executives for ALNX
|Anders KarlssonChief Executive Officer||Yvonne AxelssonChief Financial Officer|
|Lars OqvistDirector:Marketing||Ann-Cathrin JaremanDirector:QA&Regulatory Affairs|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.